What is Pragmatrix Technology?
Pragmatrix Technology is a specialized firm operating at the intersection of biotechnology and information technology. The company develops advanced software solutions designed to enhance research and development within the life sciences sector. Its core offering, the PragLife platform, is engineered to optimize workflows for organizations engaged in biologic product development and manufacturing. Pragmatrix also provides comprehensive services, including consulting, validation, training, and managed application services, all tailored to support patient-centric organizations and ultimately improve patient outcomes through intelligent automation and data analytics. With nearly two decades of industry experience, Pragmatrix is a recognized leader in its niche.
How much funding has Pragmatrix Technology raised?
Pragmatrix Technology has raised a total of $14K across 1 funding round:
Debt
$14K
Debt (2021): $14K with participation from PPP
Key Investors in Pragmatrix Technology
PPP
Public-Private Partnership
What's next for Pragmatrix Technology?
With the recent capital injection, Pragmatrix Technology is poised for accelerated expansion. The Series A/B growth stage funding suggests a strategic focus on scaling operations, enhancing product development for the PragLife platform, and potentially broadening its market reach. This investment will likely enable Pragmatrix to further solidify its position as a key technology provider for the life sciences industry, driving innovation in biologic product development and manufacturing. Future initiatives may include expanding service offerings and deepening its impact on patient outcomes through advanced data analytics and automation.
See full Pragmatrix Technology company page
